Just one dose of a new medication being tested,
lowers the risk of heart disease up to 94%.
That's according to a new study out from the Cleveland
Clinic. The medication called Lipo Tozan from Eli Lily
targets lipoprotein a, a protein in the body that
is linked to heart disease. The medication makes lipoprotein
a undetectable for 48 weeks. Researchers are particularly excited
by the study's results because lipoprotein A cannot be reduced
by diet or exercise. Heart disease is the world's
number one cause of death. And researchers are hopeful
that an annual vaccine type inject injection of the medication
could be available one day to lower the risk for 00:00:42.098 --> millions.